PREVENTION OF CANCER OF THE SKIN AND BUCCAL CAVITY

1932 ◽  
Vol 2 (7) ◽  
pp. 196-199 ◽  
Author(s):  
E. H. Molesworth
Keyword(s):  
Buccal Cavity ◽  
Prevention Of Cancer

Ultrastructural Features of the Oral Apparatus of Stentor

1976 ◽  
Vol 34 ◽  
pp. 142-143
Author(s):  
Elizabeth F. Howell
Keyword(s):  
Plasma Membrane ◽  
Osmium Tetroxide ◽  
Buccal Cavity ◽  
Fiber Bundles ◽  
Microtubular Root ◽  
Stentor Coeruleus ◽  
Root Fiber

The ultrastructure of the normal oral apparatus of Stentor has not been extensively studied. I report here on the ultrastructure of the buccal cavity of Stentor coeruleus.Stentor coeruleus was fixed in either a buffered mixture of osmium tetroxide and glutaraldehyde, or in buffered glutaraldehyde alone. Cells were then dehydrated and embedded in a mixture of Epon and Araldite.An extensive adoral zone of membranelles surrounds the anterior of the cell, and each membranelle consists of 2 parallel rows of cilia. These extend down into the buccal cavity. Two microtubular root fibers, or nemadesmata (Figs. 2 and 5), extend deeply into the cytoplasm from the base of each ciliary kinetosome. Mitochondria are usually closely associated with the root fiber bundles, and small vesicles are present between the nemadesmata of adjacent kinetosomes (Fig. 5). In the cytopharyngeal, non-ciliated areas of the buccal cavity, microtubular ribbons which extend into the cytoplasm are aligned perpendicular to the plasma membrane of the buccal cavity (Figs. 1 and 2).

Recent Patents on Anti-Cancer Potential of Helenalin

2020 ◽  
Vol 15 (2) ◽  
pp. 132-142
Author(s):  
Priyanka Kriplani ◽  
Kumar Guarve
Keyword(s):  
Synergistic Effects ◽  
Therapeutic Interventions ◽  
Active Constituent ◽  
Scientific Impact ◽  
Isolation Techniques ◽  
Anti Cancer ◽  
Prevention Of Cancer ◽  
Synthetic Derivatives

Background: Arnica montana, containing helenalin as its principal active constituent, is the most widely used plant to treat various ailments. Recent studies indicate that Arnica and helenalin provide significant health benefits, including anti-inflammatory, neuroprotective, antioxidant, cholesterol-lowering, immunomodulatory, and most important, anti-cancer properties. Objective: The objective of the present study is to overview the recent patents of Arnica and its principal constituent helenalin, including new methods of isolation, and their use in the prevention of cancer and other ailments. Methods: Current prose and patents emphasizing the anti-cancer potential of helenalin and Arnica, incorporated as anti-inflammary agents in anti-cancer preparations, have been identified and reviewed with particular emphasis on their scientific impact and novelty. Results: Helenalin has shown its anti-cancer potential to treat multiple types of tumors, both in vitro and in vivo. It has also portrayed synergistic effects when given in combination with other anti- cancer drugs or natural compounds. New purification/isolation techniques are also developing with novel helenalin formulations and its synthetic derivatives have been developed to increase its solubility and bioavailability. Conclusion: The promising anti-cancer potential of helenalin in various preclinical studies may open new avenues for therapeutic interventions in different tumors. Thus clinical trials validating its tumor suppressing and chemopreventive activities, particularly in conjunction with standard therapies, are immediately required.

Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage

2020 ◽  
Vol 10 (2) ◽  
pp. 133-148
Author(s):  
Ankaj Kaundal ◽  
Pravin Kumar ◽  
Rajendra Awasthi ◽  
Giriraj T. Kulkarni
Keyword(s):  
Buccal Cavity ◽  
Three Dimensional ◽  
Hot Water ◽  
Fickian Diffusion ◽  
Aster Ericoides ◽  
Dimensional Network ◽  
Buccal Tablet ◽  
Significant Difference ◽  
Volunteer Group

Aim: The study was aimed to develop mucoadhesive buccal tablets using Aster ericoides leaves mucilage. Background : Mucilages are naturally occurring high-molecular-weight polyuronides, which have been extensively studied for their application in different pharmaceutical dosage forms. Objective: The objective of the present research was to establish the mucilage isolated from the leaves of Aster ericoides as an excipient for the formulation of the mucoadhesive buccal tablet. Method: The mucilage was isolated from the leaves of Aster ericoides by maceration, precipitated with acetone and characterized. Tablets were prepared using wet granulation technique and evaluated for various official tests. Results: The mucilage was found to be non-toxic on A-431 and Vero cell lines. It was insoluble but swellable in cold and hot water. The results indicate that mucilage can form a three-dimensional network. The pH of the mucilage (6.82 ± 0.13) indicated that it might be non-irritant to the buccal cavity. The mucilage was found to be free from microbes. The release of drug was by Fickian diffusion. The in vivo buccal tablet acceptance was 80%. No significant difference between the diastolic blood pressure of standard and Aster tablets treated volunteer group was recorded. Conclusion: The mucilage was found to be non-toxic on A-431 and Vero cell lines. It was insoluble but swellable in cold and hot water. The results indicate that mucilage can form a three-dimensional network. The pH of the mucilage (6.82 ± 0.13) indicated that it might be non-irritant to the buccal cavity. The mucilage was found to be free from microbes. The release of drug was by Fickian diffusion. The in vivo buccal tablet acceptance was 80%. No significant difference between the diastolic blood pressure of standard and Aster tablets treated volunteer group was recorded. Other: However, to prove the potency of the polymer, in vivo bioavailability studies in human volunteers are needed along with chronic toxicity studies in suitable animal models.

Perspiria boucheri sp. nov. (Nematoda, Desmodorida) from the East China Sea

Zootaxa ◽  
2019 ◽  
Vol 4695 (2) ◽  
pp. 195-200
Author(s):  
JING SUN ◽  
HONGXIU ZHAI ◽  
YONG HUANG
Keyword(s):  
New Species ◽  
East China Sea ◽  
Buccal Cavity ◽  
Nematode Species ◽  
East China ◽  
Similar Species ◽  
Marine Nematode ◽  
The East China Sea ◽  
Free Living ◽  
China Sea

A new free-living marine nematode species from marine sediments in the East China Sea, is described here as Perspiria boucheri sp. nov. The new species is characterized by amphideal fovea surrounded partially by body annulations; four cephalic setae stout; conical buccal cavity with a minute dorsal tooth and two ventrosublateral teeth; pharynx with a pyriform terminal bulb; tail elongated, conical with 3/4 posterior cylindrical portion which having distinct coarse annulations; spicules strongly curved with narrow ventral velum, handle-shaped proximally; gubernaculum canoe-shaped, without apophysis. The new species differs from the most similar species Perspiria striaticaudata (Timm, 1962) by strongly curved spicules with handle-shaped proximal end, gubernaculum without dorsal apophysis and relatively shorter tail. Updated key to all species of Perspiria is provided. 

Description of a new species Coomansus batxatensis (Mononchida, Mononchidae) from Vietnam, with an updated key to species

2021 ◽  
Vol 95 ◽  
Author(s):  
T.T.T. Vu
Keyword(s):  
New Species ◽  
Buccal Cavity ◽  
Small Body ◽  
Molecular Data ◽  
Cavity Size ◽  
Key To Species ◽  
Tooth Apex ◽  
A New Species ◽  
Posterior Position ◽  
28S Ribosomal Dna

Abstract Coomansus batxatensis sp. nov., recorded from Vietnam, is described and illustrated and its phylogenetic relationship within the Mononchida is analysed. The molecular data (18S and 28S ribosomal DNA) are provided for the new species. The new species is characterized by small body size (body length, L = 0.7–0.9 mm); buccal cavity sub-rectangular in shape, flattened at base, 21–24 × 12–13 μm or 1.9 (1.7–2.0) times as long as wide; posterior position of dorsal tooth apex (59–63% from the base of buccal cavity); pars refringens vaginae with faint and small (2.5 × 1.7 μm) teardrop-shaped pieces, short pars distalis vaginae; and males with short spicules (50–51.5 μm) with rounded head and conical blade part. The new species is close to Coomansus parvus but differs from it by the smaller buccal cavity size, more posterior position of the dorsal tooth apex, longer tail and presence of males. An updated identification key to Coomansus species and a compendium of all the species known are presented.

scholarly journals Neurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer

2021 ◽  
Vol 22 (11) ◽  
pp. 6115
Author(s):  
Boris Mravec
Keyword(s):  
Nervous System ◽  
Animal Models ◽  
Therapeutic Potential ◽  
Clinical Findings ◽  
New Drugs ◽  
Adrenergic Signaling ◽  
Treatment And Prevention ◽  
Oncological Patients ◽  
Cancer Initiation ◽  
Prevention Of Cancer

Research on the neurobiology of cancer, which lies at the border of neuroscience and oncology, has elucidated the mechanisms and pathways that enable the nervous system to modulate processes associated with cancer initiation and progression. This research has also shown that several drugs which modulate interactions between the nervous system and the tumor micro- and macroenvironments significantly reduced the progression of cancer in animal models. Encouraging results were also provided by prospective clinical trials investigating the effect of drugs that reduce adrenergic signaling on the course of cancer in oncological patients. Moreover, it has been shown that reducing adrenergic signaling might also reduce the incidence of cancer in animal models, as well as in humans. However, even if many experimental and clinical findings have confirmed the preventive and therapeutic potential of drugs that reduce the stimulatory effect of the nervous system on processes related to cancer initiation and progression, several questions remain unanswered. Therefore, the aim of this review is to critically evaluate the efficiency of these drugs and to discuss questions that need to be answered before their introduction into conventional cancer treatment and prevention.

scholarly journals Carcinogenicity assessment: technical and political challenges

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
F Madia ◽  
A Worth ◽  
M Whelan ◽  
R Corvi
Keyword(s):  
Public Health ◽  
Safety Assessment ◽  
Chemical Exposure ◽  
Chemical Production ◽  
Chemical Safety ◽  
Cancer Disease ◽  
Cancer Occurrence ◽  
Global Trend ◽  
Exposure Patterns ◽  
Prevention Of Cancer

Abstract The rising rates of cancer incidence and prevalence identified by the WHO are of serious concern. The scientific advances of the past twenty years have helped to describe major properties of the cancer disease, enabling therapies that are more sophisticated. It has become clear that the management of relevant risk factors can also significantly reduce cancer occurrence worldwide. Public health policy actions cannot be decoupled from environmental policy actions, since exposure to chemicals through air, soil, water and food can contribute to cancer as well as other chronic diseases. Furthermore, due to the increasing global trend of chemical production including novel compounds, chemical exposure patterns are foreseen to change, posing high demands on chemical safety assessment, and creating potential protection gaps. The safety assessment of carcinogenicity needs to evolve to keep pace with changes in the chemical environment and cancer epidemiology. The presentation focusses on EC-JRC recommendations and future strategies for carcinogenicity safety assessment. This also includes discussion on how the traditional data streams of regulatory toxicology, together with new available assessment methods can inform, along with indicators of public health status based on biomonitoring and clinical data, a more holistic human-relevant and impactful approach to carcinogenicity assessment and overall prevention of cancer disease.

Sign in / Sign up

Export Citation Format

Share Document